Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era

Published:2020-02-18 Issue:5 Volume:104 Page:400-408
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Gutierrez Antonio¹^ORCID,Bento Leyre¹,Diaz‐Lopez Antonio²,Barranco Gilberto²,Garcia‐Recio Marta¹,Lopez‐Guillermo Armando³,Dlouhy Ivan³^ORCID,Rovira Jordina³,Rodriguez Mario⁴,Sanchez Pina Jose María⁴,Baile Monica⁵,Martín Alejandro⁵,Novelli Silvana⁶^ORCID,Sancho Juan‐Manuel⁷^ORCID,García Olga⁷,Salar Antonio⁸^ORCID,Bastos‐Oreiro Mariana⁹,Rodriguez‐Salazar Mª José¹⁰,Fernandez Ruben¹¹,Cruz Fatima¹²,Queizan Jose Antonio¹³,González de Villambrosia Sonia¹⁴,Cordoba Raul¹⁵,López Andres¹⁶,Luzardo Hugo¹⁷,García Daniel¹⁸,Sastre‐Serra Jordi¹⁹,Garcia Juan Fernando²²⁰,Montalban Carlos²,Cabanillas Fernando²¹,Rodríguez Jose²

Affiliation:

1. Lymphoma Unit Department of Hematology Hospital Universitari Son Espases/IdISBa Palma Spain

2. Department of Translational Research MD Anderson Cancer Center Madrid Spain

3. Hospital Clinic de Barcelona Barcelona Spain

4. Hospital Universitario 12 de Octubre Madrid Spain

5. Hospital Clinico Universitario de Salamanca (CAUSA/IBSAL) Salamanca Spain

6. Department of Hematology Hospital de la Santa Creu I Sant Pau Barcelona Spain

7. Hospital Universitari Germans Trias i Pujol Barcelona Spain

8. Department of Hematology Hospital del Mar Barcelona Spain

9. Department of Hematology Gregorio Marañón General University Hospital (HGUGM) Madrid Spain

10. Hospital Universitario de Canarias Santa Cruz de Tenerife Spain

11. Department of Hematology Hospital de Cabueñes Gijon Spain

12. Department of Hematology Hospital Virgen del Rocío Seville Spain

13. Hospital General de Segovia Segovia Spain

14. Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain

15. Department of Hematology Fundación Jimenez Díaz Madrid Spain

16. Hospital Vall d'Hebron Barcelona Spain

17. Hospital Dr. Negrin Las Palmas de Gran Canaria Madrid Spain

18. Hospital Zarzuela Madrid Spain

19. Grupo Multidisciplinar de Oncologia Traslacional IUNICS Palma Spain

20. Department of Pathology MD Anderson Cancer Center Madrid Spain

21. Auxilio Mutuo Cancer Center San Juan Spain

Funder

Consejería de Educación e Investigación

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13364

Reference26 articles.

1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

3. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

4. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

5. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study;Annals of Hematology;2023-10-20

2. The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma;European Radiology;2023-10-09

3. The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma;EUR RADIOL;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3